GR3026346T3 - Pharmaceutical compositions comprising contignasterol compounds. - Google Patents
Pharmaceutical compositions comprising contignasterol compounds.Info
- Publication number
- GR3026346T3 GR3026346T3 GR980400531T GR980400531T GR3026346T3 GR 3026346 T3 GR3026346 T3 GR 3026346T3 GR 980400531 T GR980400531 T GR 980400531T GR 980400531 T GR980400531 T GR 980400531T GR 3026346 T3 GR3026346 T3 GR 3026346T3
- Authority
- GR
- Greece
- Prior art keywords
- compounds
- pct
- hydroxyl
- contignasterol
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002086221A CA2086221C (en) | 1992-12-23 | 1992-12-23 | Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |
| PCT/CA1993/000558 WO1994014451A1 (en) | 1992-12-23 | 1993-12-21 | Pharmaceutical compositions comprising contignasterol compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3026346T3 true GR3026346T3 (en) | 1998-06-30 |
Family
ID=4150905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR980400531T GR3026346T3 (en) | 1992-12-23 | 1998-03-13 | Pharmaceutical compositions comprising contignasterol compounds. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5646138A (el) |
| EP (1) | EP0675721B1 (el) |
| JP (1) | JP3366639B2 (el) |
| AT (1) | ATE162946T1 (el) |
| AU (1) | AU673405B2 (el) |
| CA (2) | CA2086221C (el) |
| DE (1) | DE69316927T2 (el) |
| DK (1) | DK0675721T3 (el) |
| ES (1) | ES2114678T3 (el) |
| GR (1) | GR3026346T3 (el) |
| WO (1) | WO1994014451A1 (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100368425C (zh) * | 1996-07-11 | 2008-02-13 | 茵弗莱采姆药物有限公司 | 6，7－氧化的甾族化合物及其用途 |
| US6046185A (en) | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
| EP1304333A3 (en) * | 1996-07-11 | 2005-03-09 | Inflazyme Pharmaceuticals, Ltd. | 6,7-Oxygenated steroids and uses related thereto |
| SK15692002A3 (sk) | 2000-04-28 | 2003-11-04 | Inflazyme Pharmaceuticals Limited | 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5079239A (en) * | 1990-02-16 | 1992-01-07 | Harbor Branch Oceanographic Institution, Inc. | Sterol disulfates and methods of use |
-
1992
- 1992-12-23 CA CA002086221A patent/CA2086221C/en not_active Expired - Fee Related
-
1993
- 1993-12-21 AT AT94902581T patent/ATE162946T1/de not_active IP Right Cessation
- 1993-12-21 JP JP51464194A patent/JP3366639B2/ja not_active Expired - Fee Related
- 1993-12-21 EP EP94902581A patent/EP0675721B1/en not_active Expired - Lifetime
- 1993-12-21 DK DK94902581.1T patent/DK0675721T3/da active
- 1993-12-21 ES ES94902581T patent/ES2114678T3/es not_active Expired - Lifetime
- 1993-12-21 DE DE69316927T patent/DE69316927T2/de not_active Expired - Fee Related
- 1993-12-21 US US08/464,758 patent/US5646138A/en not_active Expired - Fee Related
- 1993-12-21 CA CA002152621A patent/CA2152621C/en not_active Expired - Fee Related
- 1993-12-21 AU AU56913/94A patent/AU673405B2/en not_active Ceased
- 1993-12-21 WO PCT/CA1993/000558 patent/WO1994014451A1/en active IP Right Grant
-
1998
- 1998-03-13 GR GR980400531T patent/GR3026346T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5691394A (en) | 1994-07-19 |
| CA2086221A1 (en) | 1994-06-24 |
| CA2152621A1 (en) | 1994-07-07 |
| EP0675721B1 (en) | 1998-02-04 |
| ATE162946T1 (de) | 1998-02-15 |
| DE69316927T2 (de) | 1998-10-22 |
| DK0675721T3 (da) | 1998-04-06 |
| AU673405B2 (en) | 1996-11-07 |
| JPH08504773A (ja) | 1996-05-21 |
| ES2114678T3 (es) | 1998-06-01 |
| EP0675721A1 (en) | 1995-10-11 |
| DE69316927D1 (de) | 1998-03-12 |
| CA2086221C (en) | 2003-07-15 |
| WO1994014451A1 (en) | 1994-07-07 |
| US5646138A (en) | 1997-07-08 |
| JP3366639B2 (ja) | 2003-01-14 |
| CA2152621C (en) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL109448A0 (en) | Risperidone pamoate, its preparation and pharmaceutical compositions containing it | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| PL315114A1 (en) | Compounds exhibiting properties of releasing growth hormones | |
| IL113566A0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration | |
| BG105302A (en) | Means for improving cognition | |
| TW252971B (el) | ||
| GR3026346T3 (en) | Pharmaceutical compositions comprising contignasterol compounds. | |
| FI955837A (fi) | Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi | |
| GB2266665B (en) | 5-HT1-like receptor agonist for rectal administration | |
| GR3031967T3 (en) | Ocular compositions containing steroids and their use in treating glaucoma | |
| ATE216891T1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
| HU9503099D0 (en) | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components | |
| TW261605B (el) | ||
| GR3025050T3 (en) | Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer. | |
| IL117083A (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds | |
| SI0805817T1 (el) | ||
| ATE190845T1 (de) | Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen | |
| ATE212352T1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
| MY107023A (en) | Antimalarial compositions | |
| ATE155136T1 (de) | Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| UA41376C2 (uk) | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ |